SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000061
Filing Date
2024-08-01
Accepted
2024-07-31 21:34:07
Documents
13
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 6-K a2024-08x01activitystateme.htm 6-K 20841
2 EX-99.1 exhibit991.htm EX-99.1 30374
3 exhibit991001.jpg GRAPHIC 250517
4 exhibit991002.jpg GRAPHIC 234530
5 exhibit991003.jpg GRAPHIC 304556
6 exhibit991004.jpg GRAPHIC 131373
7 exhibit991005.jpg GRAPHIC 120847
8 exhibit991006.jpg GRAPHIC 126905
9 exhibit991007.jpg GRAPHIC 102248
10 exhibit991008.jpg GRAPHIC 110675
11 exhibit991009.jpg GRAPHIC 213639
12 exhibit991010.jpg GRAPHIC 162810
13 exhibit991011.jpg GRAPHIC 118793
  Complete submission text file 0001345099-24-000061.txt   2637967
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 241163850
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)